Wird geladen...
Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke
Stroke is a leading cause of disability and death, yet effective treatments for acute stroke has been very limited. Thus far, tissue plasminogen activator has been the only FDA-approved drug for thrombolytic treatment of ischemic stroke patients, yet its application is only applicable to less than 4...
Gespeichert in:
| Veröffentlicht in: | Neural Regen Res |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5399699/ https://ncbi.nlm.nih.gov/pubmed/28469636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.202915 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|